UPDATE: BMO Capital Markets Raises PT on CareFusion Citing Adherence to Corporate Strategy
July 08, 2013 at 11:31 AM EDT
In a report published Friday, BMO Capital Markets analyst Joanne K. Wuensch reiterated an Outperform rating on CareFusion (NYSE: CFN ) and raised the price target from $38 to $41. In the report, BMO Capital Markets noted, "We reiterate our Outperform rating on shares of CFN. The stock has run
